HUTCHMED Net Debt To E B I T D A from 2010 to 2024
| HCM Stock | USD 18.08 0.32 1.80% |
Check HUTCHMED DRC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HUTCHMED DRC's main balance sheet or income statement drivers, such as , as well as many indicators such as . HUTCHMED financial statements analysis is a perfect complement when working with HUTCHMED DRC Valuation or Volatility modules.
HUTCHMED |
About HUTCHMED DRC Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include HUTCHMED DRC income statement, its balance sheet, and the statement of cash flows. HUTCHMED DRC investors use historical funamental indicators, such as HUTCHMED DRC's Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Although HUTCHMED DRC investors may use each financial statement separately, they are all related. The changes in HUTCHMED DRC's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on HUTCHMED DRC's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on HUTCHMED DRC Financial Statements. Understanding these patterns can help to make the right decision on long term investment in HUTCHMED DRC. Please read more on our technical analysis and fundamental analysis pages.
HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchmed China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2110 people.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as HUTCHMED DRC using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in HUTCHMED Stock
When determining whether HUTCHMED DRC is a strong investment it is important to analyze HUTCHMED DRC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact HUTCHMED DRC's future performance. For an informed investment choice regarding HUTCHMED Stock, refer to the following important reports:Check out the analysis of HUTCHMED DRC Correlation against competitors. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.